- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 21, 2022
Discovery & Translation
Oncorus’ synthetic RNA viruses for immunotherapy; plus Sisu’s small molecule for AML and more
BioCentury’s roundup of translational news
BioCentury | Jun 2, 2022
Distillery Therapeutics
Targeting CYLD to promote neuron survival in Parkinson's
Items per page:
1 - 5 of 5